WASHINGTON, Jan 11 (Reuters) - The U.S. authorities volition denote a database of 10 medicine drugs for which it plans to negociate the prices for Medicare recipients connected Sept. 1, and the prices a twelvemonth later, a apical Biden medication authoritative said connected Wednesday.
President Joe Biden successful August signed into instrumentality the Inflation Reduction Act, which among its provisions for the archetypal clip allows the national Medicare wellness program for radical property 65 and older and the disabled to negociate prices connected immoderate of the astir costly drugs.
The U.S. Department of Health and Human Services (HHS) and the Centers of Medicare & Medicaid Services (CMS) - which oversees Medicare and the dialog process - announced the circumstantial timeline for the archetypal twelvemonth of negotiations connected Wednesday.
It had antecedently said it would merchandise the names of the 10 Part D high-spend marque sanction medicines that would beryllium included successful pricing negotiations successful the autumn of 2023.
In September of 2024, CMS expects to people the negotiated "maximum just price" that would go effectual successful 2026, CMS Administrator Chiquita Brooks-LaSure said connected a telephone with reporters.
(This communicative has been corrected to hole the timing of announcement connected prices to 2024 successful paragraph 1)
Reporting by Ahmed Aboulenein; Additional reporting by Leroy Dsouza successful Bengaluru; Editing by Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles.
English (US)